| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/17/2007 | US7244454 Chewing gum product including encapsulated aspartame and sodium bicarbonate and process of preparing |
| 07/17/2007 | US7244451 Contacting a poorly soluble drug with a vinyl acetate-vinyl pyrrolidone copolymer to absorb the polymer to the surface of the drug |
| 07/17/2007 | US7244450 coadministration of liposome-encapsulated vincristine with Rituximab; anticarcinogenic agents; relapsed non-Hodgkin's Lymphoma |
| 07/17/2007 | US7244449 Liposome-entrapped topoisomerase inhibitors |
| 07/17/2007 | US7244448 Providing liposome having free active agent and precipitated active agent encapsulated therein; varying amount of active agent that is precipitated in liposome for modulation plasma circulation half-life of active agent |
| 07/17/2007 | US7244447 Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
| 07/17/2007 | US7244446 Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide |
| 07/17/2007 | US7244444 Graft material, stent graft and method |
| 07/17/2007 | US7244440 artificial tears or vehicles for ophthalmic drugs; viscosity; hydroxypropyl methylcellulose and a combination of two other polymers: guar gum, a carboxyvinyl polymer (polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol), hydroxyethyl cellulose or dextran |
| 07/17/2007 | US7244439 Cosmetic composition |
| 07/17/2007 | US7244426 Pharmaceutical compositions of fibrinolytic agent |
| 07/17/2007 | US7244425 Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
| 07/17/2007 | US7244418 For therapy of microbial infection of a nail plate |
| 07/17/2007 | US7244415 Suspension of crystalline tiotropium bromide anhydrate in the propellant gases HFA 227 and/or HFA 134a |
| 07/17/2007 | US7244414 Administering fine powder of active material; measured aerosol |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | CA2431848C Method of producing chewing gum containing caffeine and gum produced thereby |
| 07/17/2007 | CA2389235C Controlled release hydrocodone formulations |
| 07/17/2007 | CA2339836C Active ingredient support in the form of a film |
| 07/17/2007 | CA2306628C Cosmetic formulations for the prevention and therapy of hair loss |
| 07/17/2007 | CA2300339C Transdermal therapeutic system containing the active substance scopolamine base |
| 07/17/2007 | CA2298445C Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 07/17/2007 | CA2254958C Methods for sterilizing female mammals |
| 07/17/2007 | CA2233016C Anthelmintic macrocyclic lactone compositions |
| 07/17/2007 | CA2172506C Mycophenolate mofetil and mycophenolic acid high dose oral suspensions |
| 07/17/2007 | CA2170879C Diagnostic uses of hydrazinoadenosines |
| 07/17/2007 | CA2115348C Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes |
| 07/17/2007 | CA2054438C Additives to feminine hygiene products |
| 07/12/2007 | WO2007079389A2 Composition and method of use thereof |
| 07/12/2007 | WO2007079252A2 Sustained release pharmaceutical compositions |
| 07/12/2007 | WO2007079198A2 Metaxalone formulations and methods for the preparation thereof |
| 07/12/2007 | WO2007079191A2 System for characterizing a patient's propensity for a neurological event |
| 07/12/2007 | WO2007079083A1 Encapsulated chromonic particles |
| 07/12/2007 | WO2007079082A2 Gastric release pulse system for drug delivery |
| 07/12/2007 | WO2007078895A2 Modified release formulations of tramadol and uses thereof |
| 07/12/2007 | WO2007078879A2 Lipopeptide compositions and methods of use thereof |
| 07/12/2007 | WO2007078874A2 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| 07/12/2007 | WO2007078485A1 Novel hair treatment compositions |
| 07/12/2007 | WO2007078402A2 A layered dosage form for a medicated tampon assembly |
| 07/12/2007 | WO2007078290A1 Adhesively bonded dosage form |
| 07/12/2007 | WO2007078271A2 Lansoprazole orally disintegrating tablets |
| 07/12/2007 | WO2007077990A1 Drug delivery material |
| 07/12/2007 | WO2007077806A1 Pharmaceutical composition for application to nail |
| 07/12/2007 | WO2007077783A1 Composition for soft contact lens and adsorption suppressing method |
| 07/12/2007 | WO2007077741A1 Transdermally absorbable preparation |
| 07/12/2007 | WO2007077656A1 Liquid medicine for internal use |
| 07/12/2007 | WO2007077640A1 Skin patch and method of producing the same |
| 07/12/2007 | WO2007077639A1 Adhesive patch |
| 07/12/2007 | WO2007077581A2 Pharmaceutical compositions |
| 07/12/2007 | WO2007077529A2 Oral, pulmonary and transmucosal delivery composition |
| 07/12/2007 | WO2007077421A1 Pack |
| 07/12/2007 | WO2007077328A1 Novel essential-oil-based pharmaceutical composition for nasal and/or oral spray |
| 07/12/2007 | WO2007077252A1 Concentrated liquid thyroid hormone composition |
| 07/12/2007 | WO2007077158A1 Pharmaceutical compositions for the eradication of helicobacter pylori |
| 07/12/2007 | WO2007077029A1 Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers |
| 07/12/2007 | WO2007076874A1 Disintegrating loadable tablets |
| 07/12/2007 | WO2007076864A1 Adhesive with egg white |
| 07/12/2007 | WO2007076852A1 Self-adhesive semi-occlusive plaster dressing for atopical dermatitis |
| 07/12/2007 | WO2007076699A1 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparing process and application |
| 07/12/2007 | WO2007076619A1 Pharmaceutical composition for the treatment of nail diseases |
| 07/12/2007 | WO2007062262A3 Gelatinous medicament formulation and method of administration |
| 07/12/2007 | WO2007062107A3 Immunostimulatory oligoribonucleotides |
| 07/12/2007 | WO2007061739A3 Pharmaceutical compositions comprising buprenorphine |
| 07/12/2007 | WO2007058800A3 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 07/12/2007 | WO2007056264A3 Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
| 07/12/2007 | WO2007050294A3 Liquid dosage forms having enteric properties of delayed and then sustained release |
| 07/12/2007 | WO2007047040A3 Directly compressible extended release alprazolam formulation |
| 07/12/2007 | WO2007044319A3 Methods of preparing polymers having terminal amine groups using protected amine salts |
| 07/12/2007 | WO2007042833A3 Arnphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents |
| 07/12/2007 | WO2007041410A3 Sustained release small molecule drug formulation |
| 07/12/2007 | WO2007038549B1 Treatment of inflammation and vascular abnormalities of the eye |
| 07/12/2007 | WO2007038315A3 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients |
| 07/12/2007 | WO2007034503A3 Controlled release dosage formulation of duloxetine |
| 07/12/2007 | WO2007034207A3 Troventol formulation |
| 07/12/2007 | WO2007031265A3 Combinations comprising a vegf receptor inhibitor and a penetration enhancer |
| 07/12/2007 | WO2007029268B1 Stable oxaliplatin formulation |
| 07/12/2007 | WO2007029093A3 Pharmaceutical dosage forms of oxcarbazepine |
| 07/12/2007 | WO2007029087A3 Controlled release multiple unit formulations |
| 07/12/2007 | WO2007026307A3 Encapsulated active ingredients, methods of preparation and their use |
| 07/12/2007 | WO2007020505A3 Medicinal forms of phospholipid preparations and methods for their preparation |
| 07/12/2007 | WO2007020079A3 Orally disintegratable simvastatin tablets |
| 07/12/2007 | WO2007016501A3 Compositions and method for brain specific targeted delivery of therapeutic agents |
| 07/12/2007 | WO2007012977A3 Steroid kit and foamable composition and uses thereof |
| 07/12/2007 | WO2007012974A3 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 07/12/2007 | WO2007011972A3 Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
| 07/12/2007 | WO2007011763A3 Adhesive sheet and methods of use thereof |
| 07/12/2007 | WO2007005565A3 Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method |
| 07/12/2007 | WO2007001067A3 Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
| 07/12/2007 | WO2006129160A3 Stable aqueous oral solution of risperidone |
| 07/12/2007 | WO2006126212A3 Epidermal growth factor composition, a process therefor and its application |
| 07/12/2007 | WO2006123360A3 Microspheres containing octreotide acetate |
| 07/12/2007 | WO2006123243A3 Pharmaceutical dosage forms comprising escitalopram in form of granules |
| 07/12/2007 | WO2006091795A3 METHODS AND COMPOSITIONS INVOLVING EXPRESSION OF α1C SUBUNIT OF L-TYPE CALCIUM CHANNELS IN SMOOTH MUSCLE CELLS |
| 07/12/2007 | WO2006068779A3 Compositions and methods of their use for improving the condition and appearance of skin |
| 07/12/2007 | WO2006050836A3 Ophthalmic emulsions containing prostaglandins |
| 07/12/2007 | WO2005107455A3 Antimicrobial coating for inhibition of bacterial adhesion and biofilm formation |
| 07/12/2007 | WO2004104166A3 Administration of hyaluronic acid to enhance the function of transplanted stem cells |
| 07/12/2007 | WO2003077723A3 Methods and devices for detection and therapy of atheromatous plaque |
| 07/12/2007 | US20070161711 Process for producing pellets for pharmaceutical compositions |
| 07/12/2007 | US20070161601 Propofol formulation containing reduced oil and surfactants |